Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR), and the Italian Cancer Society (SIC), the EACR-AACR-SIC Special Conference 2017 will build on the success of the previous conference, which was widely praised for the quality of its program and inspirational contributions.
The conference format is designed to bring together basic, translational, and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort. The program will comprise Keynote Lectures, Plenary Symposia, Scientific Symposia, Meet-the-Expert sessions, and Oral and Poster presentations with ample time for discussion.
It will provide up-to-date information on both targeted and immunological approaches to interfere with cancer, for which major progress has been made in recent years. Along with these encouraging developments, the program will focus on the challenges that lie ahead of us—to increase our fundamental understanding of tumor heterogeneity and drug resistance mechanisms, to better stratify patients for therapy, and to increase the numbers of patients with durable clinical responses. Furthermore, ample attention will be given to the role of the microbiome and other microenvironmental factors influencing therapy response. Finally, technical advances like single-cell sequencing and relevant in vivo/ex vivo models will be covered. The program will offer high value through Plenary and Poster sessions, providing an excellent forum to share new data and network with colleagues.
CELL AND TUMOUR BIOLOGY
Cell Proliferation/cell cycle
Cell Death / Autophagy
Oncogenes and Tumour Suppressor Genes
Tumour Progression: Invasion and Metastasis
Metastases and EMT
Tumour Microenvironment
Tumour Angiogenesis
Tumour Immunology AND Inflammation
Aging and Cancer
Senescence
Cancer Cell Metabolism
Cancer Initiating Cells / Cancer Stem Cells
Tumour heterogeneity
CANCER GENOMICS, EPIGENETICS and GENOMIC INSTABILITY
Genomic Alterations in Cancer
Functional Genomics
Epigenetic mechanisms and RNA
Genetic instability
Deep sequencing
SIGNALING PATHWAYS
Receptors and Signal Transduction
Gene Expression, Transcriptional Regulation
Systems biology
Computational models of biological systems
Omics technologies
CARCINOGENESIS
Mutagenesis, Carcinogen Metabolism
Promotion and Progression
DNA Damage and Repair
Viral Oncogenesis
TRANSLATIONAL RESEARCH
Organ Site-Specific Investigations: Preclinical, Diagnosis, Treatment
Molecular pathology
Biomarkers with clinical relevance, imaging
Prognostic biomarkers of therapy response
Prognostic value of oncogenomics
Clinical Phase I/II trials with targeted drugs and novel agents
Bioinformatics in therapies and clinical trials
Animal models of cancer
Infrastructures (biobanks, databases, genomic resources, others)
EXPERIMENTAL / MOLECULAR THERAPEUTICS, PHARMACOGENOMICS
Drug Discovery / Drug Design
Novel Targets, Delivery Systems
Mechanisms of Drug Action, Drug Profiling
Drug Resistance
Novel Approaches to Diagnosis of Cancer
New Therapies
Companion diagnostics
Personalized medicine
TUMOUR IMMUNOLOGY
Tumour Immunology
Immune Suppression and Escape
Tumor antigens and immune effectors
Immunotherapy and Cancer Vaccines
Cancer vaccines: preclinical and clinical studies
RADIOBIOLOGY / RADIATION ONCOLOGY
Tumour Cell Sensitization to Radiotherapy
Radiation-activated Signaling Pathways
Cell Cycle and Apoptosis in Radiation Responses
Radiation Oncology; Preclinical and Clinical
Translational radiation research
MOLECULAR AND GENETIC EPIDEMIOLOGY
Risk Factors
Biomarkers
Risk Assessment
Susceptibility Genes
Genotype / Phenotype Correlations
Genetic Polymorphisms and Cancer Susceptibility
Epidemiology
PREVENTION and EARLY DETECTION
Preclinical Prevention Studies, Markers and Prevention
Clinical Prevention Studies
Vaccination Against Cancer
MOUSE MODELS
Transgenic models
Chemical carcinogenesis
PDXs
Humanised mouse models
OTHER
06月24日
2017
06月26日
2017
摘要截稿日期
注册截止日期
留言